The CYP7B1 gene SPG5A genetic test is a specialized diagnostic tool designed to identify mutations in the CYP7B1 gene, which are linked to Spastic Paraplegia 5A (SPG5A). SPG5A is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive weakness and spasticity of the legs. Mutations in the CYP7B1 gene disrupt the normal function of enzymes involved in cholesterol metabolism, leading to the symptoms associated with SPG5A.
This genetic test involves analyzing the patient's DNA to detect specific mutations in the CYP7B1 gene that are known to cause SPG5A. It is a crucial step in the diagnosis of SPG5A, allowing for a precise genetic diagnosis that can inform treatment strategies, provide information on the course of the disease, and offer insight into the risk of passing the condition on to future generations.
The test is available at DNA Labs UAE, a leading facility for genetic testing in the United Arab Emirates. The cost of the CYP7B1 gene SPG5A genetic test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive analysis involved in identifying the genetic mutations associated with SPG5A, utilizing advanced genomic technologies to ensure accurate and reliable results. Patients considering this test should consult with a healthcare professional or genetic counselor to understand the implications of the test results and to receive personalized advice based on their specific situation.
The NIPA1 Gene SPG6 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the NIPA1 gene, which are associated with Spastic Paraplegia 6 (SPG6), a rare genetic disorder. This condition is characterized by progressive weakness and stiffness of the legs, which can lead to difficulty walking and other mobility issues. The test aims to provide definitive genetic evidence for the condition, aiding in accurate diagnosis and management.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific mutations in the NIPA1 gene that are known to cause SPG6. This precise genetic testing can be crucial for affected individuals and their families for understanding the condition, potential treatments, and genetic counseling.
The cost of the NIPA1 Gene SPG6 Genetic Test at DNA Labs UAE is 4400 AED. While the price might seem significant, the value of obtaining a precise diagnosis cannot be overstated, as it opens the door to targeted interventions and supports planning for the future.
The WDR48 gene, associated with SPG60 (Spastic Paraplegia 60), plays a crucial role in various cellular processes, including the regulation of autophagy and endosomal trafficking. Mutations in the WDR48 gene can lead to SPG60, a form of hereditary spastic paraplegia characterized by progressive weakness and spasticity of the lower limbs. The condition may also present additional neurological symptoms depending on the severity and specific mutation involved.
To diagnose and understand the genetic basis of SPG60 in affected individuals, DNA Labs UAE offers a specialized genetic test targeting the WDR48 gene. This test is designed to identify mutations within the WDR48 gene that could be responsible for the condition, providing essential information for accurate diagnosis, management, and genetic counseling.
The cost of the WDR48 gene-related genetic test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted in a state-of-the-art facility, ensuring high accuracy and reliability of the results. By opting for this test, patients and their families can gain valuable insights into the genetic underpinnings of SPG60, facilitating informed decisions regarding treatment options and lifestyle adjustments to better manage the condition.
The ARL6IP1 gene, associated with SPG61, is a critical genetic marker for diagnosing hereditary spastic paraplegia type 61 (SPG61), a rare neurodegenerative disorder. This condition is characterized by progressive weakness and spasticity of the lower limbs due to the degeneration of the corticospinal tract neurons. The ARL6IP1 gene plays a significant role in the maintenance and function of the nervous system, and mutations in this gene can lead to the clinical manifestations of SPG61.
To accurately diagnose this condition, a genetic test targeting the ARL6IP1 gene can be conducted. In the UAE, this specialized test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The test involves analyzing the patient's DNA to identify mutations in the ARL6IP1 gene that are indicative of SPG61. This genetic test is crucial for confirming the diagnosis, understanding the prognosis, and guiding the management and treatment plans for affected individuals.
The cost of the ARL6IP1 gene SPG61 genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any genetic alterations in the ARL6IP1 gene, providing patients and their families with essential information for managing the condition. Given the complexity of hereditary spastic paraplegia and the importance of early intervention, this genetic test is a valuable tool in the diagnostic process, offering insights that can significantly impact the quality of life of those affected by SPG61.
The ERLIN1 gene, associated with SPG62 (a form of hereditary spastic paraplegia), plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a range of neurological symptoms, primarily affecting mobility and muscle control. To diagnose this condition, a genetic test targeting the ERLIN1 gene can be conducted.
This specific test, available at DNA Labs UAE, is designed to identify mutations in the ERLIN1 gene that are linked to SPG62. By analyzing a patient's DNA sample, the test can provide essential information for diagnosis, allowing for a better understanding of the condition and aiding in the development of a targeted treatment plan.
The cost of the ERLIN1 related genetic test at DNA Labs UAE is 4400 AED. This price includes the comprehensive analysis required to detect any genetic abnormalities associated with the ERLIN1 gene. Given the complexity and the specialized nature of this genetic test, the cost reflects the advanced technology and expertise required to accurately identify mutations in the ERLIN1 gene and provide patients with critical information about their condition.
The AMPD2 Gene SPG63 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the AMPD2 gene, which are associated with Spastic Paraplegia 63 (SPG63). SPG63 is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive stiffness and weakness of the legs. The AMPD2 gene plays a critical role in the development and maintenance of the nervous system, and mutations in this gene can lead to various neurological symptoms, including difficulties with walking and coordination.
This genetic test involves analyzing the patient's DNA to detect any abnormalities in the AMPD2 gene that could lead to SPG63. It is a crucial tool for healthcare providers in diagnosing this rare condition, enabling them to offer appropriate management and treatment options for affected individuals. Early diagnosis can also help in understanding the progression of the disease and in providing genetic counseling to families.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the AMPD2 Gene SPG63 Genetic Test is 4400 AED. DNA Labs UAE employs advanced genetic testing technologies and methodologies to ensure accurate and reliable results, offering patients and their families critical insights into their genetic health.
The ENTPD1 Gene SPG64 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the ENTPD1 gene, which are associated with Spastic Paraplegia 64 (SPG64). This condition is a form of hereditary spastic paraplegia, characterized by progressive weakness and stiffness of the legs. The test plays a crucial role in the early detection and management of SPG64, enabling healthcare providers to tailor interventions and support to the specific needs of individuals affected by this condition.
The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic alterations in the ENTPD1 gene. This comprehensive analysis helps in confirming the diagnosis, understanding the disease's progression, and informing potential treatment strategies.
The cost of the ENTPD1 Gene SPG64 Genetic Test at DNA Labs UAE is set at 4400 AED. This investment covers the full spectrum of services, from the initial collection of the sample to the detailed analysis and reporting of results. By choosing DNA Labs UAE for this genetic testing, patients and healthcare providers can expect accurate, reliable, and timely results, aiding in the effective management of Spastic Paraplegia 64.
The ARSI Gene SPG66 ARSI Related Genetic Test is a specialized genetic analysis aimed at detecting mutations in the ARSI gene, which are linked to the development of Spastic Paraplegia 66 (SPG66). This condition is a form of hereditary spastic paraplegia, a group of genetic disorders characterized by progressive weakness and stiffness of the legs. Early diagnosis through genetic testing can be crucial for managing symptoms and planning treatment strategies.
Performed at DNA Labs UAE, this test is designed with precision to identify the specific genetic alterations within the ARSI gene. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies. This ensures a high level of accuracy in detecting any mutations that may be present.
The cost of the ARSI Gene SPG66 ARSI Related Genetic Test is set at 4400 AED. While the price might seem significant, the value of the information it provides for affected individuals and their families can be invaluable. This test not only aids in the confirmation of a diagnosis but also helps in understanding the genetic basis of the condition, which can be essential for genetic counseling and making informed decisions about family planning.
DNA Labs UAE is known for its commitment to providing high-quality genetic testing services, ensuring confidentiality and support throughout the testing process. By opting for this test, individuals gain access to crucial genetic insights, paving the way for a better-informed approach to managing and living with Spastic Paraplegia 66.
The HSPD1 Gene SPG13 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the HSPD1 gene, which are associated with spastic paraplegia 13 (SPG13), a rare genetic disorder. This condition is part of a group of hereditary spastic paraplegias that primarily affect the lower limbs, leading to progressive muscle weakness and stiffness (spasticity). The test plays a crucial role in the early detection and management of the disorder, enabling healthcare providers to tailor treatments and interventions more effectively.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab. The sample is then analyzed using advanced genetic sequencing technologies to identify any mutations in the HSPD1 gene that may be indicative of SPG13.
The cost of the HSPD1 Gene SPG13 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the value of the information it provides for affected individuals and their families cannot be overstated. Early diagnosis can significantly impact the quality of life, enabling those affected to access supportive therapies and interventions sooner.
Patients considering this test are encouraged to consult with their healthcare provider to understand its implications fully and discuss any concerns they may have about the genetic testing process.
The ZFYVE26 gene, associated with Spastic Paraplegia 15 (SPG15), is a crucial genetic marker for diagnosing this rare and complex form of hereditary spastic paraplegia. SPG15 is characterized by progressive weakness and stiffness of the legs, and it can also affect the brain and peripheral nervous system, leading to a wide range of symptoms including vision loss, cognitive impairment, and thinning of the corpus callosum. The condition follows an autosomal recessive pattern of inheritance, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The ZFYVE26 Gene SPG15 Genetic Test is a sophisticated diagnostic tool aimed at detecting mutations in the ZFYVE26 gene, offering crucial information for the diagnosis, management, and genetic counseling of affected individuals and their families. Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test represents a critical step towards personalized medicine for patients dealing with SPG15.
The cost of the ZFYVE26 Gene SPG15 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the meticulous process of DNA analysis to identify the presence of mutations associated with the condition. Given the complexity of hereditary spastic paraplegia and the importance of accurate diagnosis for effective management and treatment planning, this test provides invaluable insights for affected individuals and their healthcare providers.
